Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Boston Scientific Corp BSX

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.


NYSE:BSX - Post by User

Post by johnson021on Sep 09, 2022 6:39am
180 Views
Post# 34951468

Cannula Market Trends, Share, Demand & Size 2022-2027

Cannula Market Trends, Share, Demand & Size 2022-2027

The latest research study “Cannula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” Offers a comprehensive analysis of the industry, which comprises insights on cannula market share.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/cannula-market/requestsample

Industry Definition and Application:

The global cannula market size reached US$ 138.7 Million in 2021. A cannula refers to a small hollow tube with a retractable and sharp inner core that is inserted into an artery, vein, or body for administering medication and drawing off fluids. It is available in several product variants, including cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas, etc. Cannula tubes are extensively used for injecting fillers as it reduces the risk of bleeding and bruising, cause lesser pain, and provide greater flexibility as compared to hypodermic needles. Consequently, they find widespread applications across numerous segments of the healthcare sector, such as hospitals, blood banks, Ambulatory Surgery Centers (ASCs), laboratories, pathology labs, etc.

Cannula Market Industry Trends and Drivers:

The growing prevalence of chronic diseases, including cardiovascular illnesses, diabetes, obesity, etc., and the elevating number of surgical procedures being performed around the world, are primarily driving the cannula market. Additionally, the expanding geriatric population, and the escalating inclination toward minimally invasive surgeries (MIS) that ensure less surgical trauma, minimized infection risks, and smaller scars are further stimulating the market growth. Moreover, the rising popularity of cosmetic surgeries is acting as another significant growth-inducing factor. Apart from this, the increasing advancements in healthcare facilities in the emerging nations and the inflating investment undertaken by leading vendors in research and development (R&D) activities for introducing advanced products such as a bidirectional arterial cannula to reduce the risk of limb ischemia are expected to propel the cannula market over the forecasted period. Looking forward, IMARC Group expects the market to reach US$ 206.6 Million by 2027, exhibiting a CAGR of 7.4% during 2022-2027.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/cannula-market

Companies Covered:

Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated and Terumo Corporation

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Product:

Cardiac Cannulas
Nasal Cannulas
Vascular Cannulas
Dermatology Cannulas
Arthroscopy Cannulas
Others

Cardiac cannulas currently represent the largest market segment due to the growing global population and the rising prevalence of cardiovascular diseases across the globe.

Breakup by Type:

Neonatal Cannulas
Straight Cannulas
Winged Cannula
Wing with Port Cannula
Others

Straight cannulas are the most used variants as they are equipped with an extra sharp needle that makes it easier to insert into veins or arteries.

Breakup by Size:

14G
16G
18G
20G
22G
24G
26G

18 G cannulas account for the majority of the global cannula market share as they are extensively used in hospitals to infuse products and deliver medications.

Breakup by Material:

Plastic (PVC) Cannulas
Silicone Cannulas
Metal Cannulas (Stainless Steel)

Plastic (PVC) cannulas currently hold the largest market share due to their widespread adoption in both in-patient and out-patient procedures.

Breakup by Application:

Cardiovascular Surgery
Oxygen Therapy
General Surgery
Cosmetic/Plastic Surgery
Orthopedic Surgery
Others

Breakup by End-User:

Hospitals
Ambulatory Surgery Centers (ASCs)
Others

Hospitals presently dominate the market on account of the rising prevalence of chronic medical disorders and increasing accidents and the hospitalization rate.

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts
Next >>